Analysis results On May 4, 2026, a team at UMC Heart Center successfully performed the first implantation of a biventricular mechanical circulatory support system (Bi-VAD) on an animal in the CIS countries. The procedure took place at the new Biomedical Research Center of Nazarbayev University in Astana.
The implantation of the DuoCor2 device was carried out by the UMC Heart Team under the leadership of Dr. Yuriy Pya, in collaboration with HXCOREMED and Global Medical. Kazakhstan became only the fourth country in the world to perform this type of procedure.
Heart failure continues to be one of the leading causes of mortality globally. While LVAD technologies have significantly improved outcomes for patients with left ventricular failure, patients with right ventricular failure still face limited treatment options and high risks. Bi-VAD systems such as DuoCor2 are designed to support both systemic and pulmonary circulation, offering new possibilities for patients with severe biventricular heart failure.
This preclinical study marks another important step in the development of biomedical engineering, mechanical circulatory support technologies, and translational cardiovascular research in Kazakhstan. At UMC, collaboration with global innovators and the implementation of advanced medical technologies remain central to our mission of expanding access to cutting-edge treatment and strengthening scientific research in the region.
